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The Myth of the Mild Vulnerable Plaques
Gregg W. Stone, MD,* Jagat Narula, MD, PHDyew core concepts introduced in the past
several decades have become more ingrained
in the psyche of the cardiologist such as the
belief that coronary occlusion and myocardial
infarction most frequently evolve from a mildly
stenotic coronary artery disease (1). This perception
owes its origin to the observations made 25 years ago
that among patients in whom coronary angiography
had been performed at some point, days to years
before a myocardial infarction, the lesion responsible
for the subsequent infarct was angiographically less
than severe in the majority of cases (2,3). Over the
years, this hypothesis has been supported by other
angiographic studies, most convincingly from the
National Heart, Lung, and Blood Institute’s Dy-
namic Registry (4), the PROSPECT (Predictors of
Response to Cardiac Resynchronization Therapy)
trial (5), and the COURAGE (Clinical Outcomes
Utilizing Revascularization and Aggressive Drug
Evaluation) trial (6), although notably challenged by
CASS (Coronary Artery Surgery Study) (7). How-
ever, all these studies do not take into account the
interval progression of lesion severity that may occur
before coronary thrombosis. Angiographic studies
performed during a myocardial infarction purporting
to reveal underlying plaque severity after thrombol-
ysis (8) or aspiration (9) are less compelling given
the inability of these modalities to completely
remove thrombus. Although fraught with selection
bias, a pathologic study of patients recently dying
after myocardial infarction or sudden cardiac death
has suggested that the fateful plaques were almost
always at least moderately occlusive and that the
vulnerable plaques probably expanded in size before
they ruptured (10). PROSPECT (5), which relied
on intravascular imaging rather than angiography,
suggested that the lesions responsible for futureFrom the *Columbia University Medical Center and the Cardiovascular
Research Foundation, New York, New York; and the yIcahn School of
Medicine at Mount Sinai, New York, New York.acute coronary syndromes (ACS) were indeed not
mild but rather were in all cases moderate or severe.
In this issue of iJACC, we posed the question “Are
the culprit lesions severely stenotic?” and received 2
diametrically opposed opinions from Niccoli et al.
(No!), and Ambrose and Berg (Yes!) (11). Both
groups buttress their positions with detailed data
from studies correlating imaging results with clinical
end points. Each treatise also discusses the limitations
of the published studies. Thus, how can we reconcile
these conﬂicting results? Or are both positions correct
(and if so, how is this possible)? The answer lies in
understanding the limitations of coronary angiog-
raphy as an imaging method (12). First, the angio-
gram is in fact a “luminogram,” incapable of revealing
plaque that resides in the vascular tunica media
and adventitia that does not narrow the inner
diameter of the coronary vessel (13). This is partic-
ularly relevant because plaque accumulation results in
vessel expansion before luminal compromise (14).
This compensatory mechanism is usually overcome
when the plaque occupies approximately 40% of
cross-sectional vascular area (or plaque burden),
with progressive atherosclerosis thereafter resulting
in luminal encroachment. Thus, by the time a lesion
in a coronary artery with a 3.0-mm reference vessel
diameter appears angiographically mild (e.g., 33%
diameter stenosis), the external elastic membrane of
the vessel may have swollen to 5.5 mm or greater, and
the plaque burden may in truth be>85%. Indeed, the
fact that coronary angiography can markedly under-
estimate the pathologic degree of atherosclerosis was
elegantly demonstrated 40 years ago (15). Second,
the angiogram is a 2-dimensional representation
of a complex 3-dimensional structure. Given plaque
eccentricity (which is the rule rather than the
exception), angiography may either overestimate
or underestimate the true cross-sectional lesion
severity, depending on the incident angle of the x-
ray beam as it transects the narrowed lumen
(10,13). For all of these reasons, the angiogram is a
gold standard, which we should not rely upon
for lesion analysis. In this regard, tomographic
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thology as a gold standard (10).
When trying to weigh the strength of data from
conﬂicting sources, the strongest evidence usually
resides in prospective studies formulated to answer
the issue in question. In this regard, the multicenter
PROSPECT study was designed to overcome the
limitations of prior studies, prospectively enrolling
697 patients in whom angiography and 3-vessel
intravascular imaging with grayscale and radio-
frequency ultrasound was performed to characterize
those untreated nonculprit lesions responsible for
future ACS events (5). With median follow-up of
3.4 years, the strongest predictor of future events
was the intravascular ultrasound (IVUS)–derived
plaque burden at the nonculprit lesion. The per
lesion event rate was 9.5% for the 298 untreated
lesions in which plaque burden was $70%, 2.5% for
the 798 lesions in which plaque burden was$60% to
70%, and <0.5% for thousands of lesions with
<60% plaque burden (16). Indeed, not a single
adverse event arose from a segment of the coronary
tree with <40% plaque burden. The minimal
luminal area was also an independent predictor of
future ACS events. And given the space occupying
nature of the measuring catheter, IVUS may un-
derestimate the true severity of lesions with the
greatest luminal narrowing. Of note, although le-
sions destined to cause future ACS were severe by
IVUS, by quantitative coronary angiography, the
mean angiographic diameter stenosis of these lesions
was only 32.3%, although they did progress to 65.4%
at the time of the future event, consistent with rapid
lesion progression due to plaque rupture and/or
coronary thrombosis. The fact that plaque burden
was the most powerful predictor of future ACSevents was subsequently conﬁrmed in the single-
center prospective VIVA (VH-IVUS in Vulnerable
Atherosclerosis) study, which was of similar design
as PROSPECT (17). The information available
from the analyses of pathological specimens that
compared the vulnerable plaques and ruptured pla-
ques demonstrated that the plaque burden was
substantially higher in the latter; this indirectly
suggested that the plaques expand further before
rupture.
PROSPECT (and VIVA) have thus demonstrated
that lesions responsible for future major adverse car-
diac events are both mild and severe: mild by angi-
ography (as deﬁned by the luminal diameter stenosis
relative to the adjacent reference lumens) but severe by
IVUS (as deﬁned by large atheroma volume with
severe cross-sectional area narrowing), the latter more
accurately reﬂecting the truth. These studies have also
suggested that the lesions must further expand during
the interval between the initial assessment of vulner-
able lesion and the subsequent event (10). This is
mechanistically credible, because studies have re-
ported that the greater the volume of atheroma, the
greater the burden of lipid and necrotic core, the
thinner the ﬁbrous cap, the more severe the inﬂam-
mation, the more deranged the vaso vasorum, and the
more abnormal the stress-strain relationships (18,19).
Should we then bury the myth that vulnerable plaques
are milddand stop relying on coronary angiography
for sophisticated lesion analysis?Address for correspondence: Dr. Jagat Narula, Icahn
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